ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
78.71
-0.04
(-0.05%)
마감 23 1월 6:00AM
78.65
-0.06
(-0.08%)
시간외 거래: 9:59AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
78.71
매수가
76.28
매도가
79.95
거래량
1,144,598
77.60 일간 변동폭 79.14
61.16 52주 범위 85.57
market_cap
전일 종가
78.75
개장가
78.19
최근 거래 시간
1
@
79.77
마지막 거래 시간
재정 규모
US$ 89,872,916
VWAP
78.5192
평균 볼륨(3m)
903,963
발행 주식
158,891,800
배당수익률
0.41%
주가수익률
74.40
주당순이익(EPS)
1.06
매출
1.16B
순이익
168.11M

Bio Techne Corporation 정보

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
본부
Minneapolis, Minnesota, USA
설립됨
-
Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker TECH. The last closing price for Bio Techne was US$78.75. Over the last year, Bio Techne shares have traded in a share price range of US$ 61.16 to US$ 85.57.

Bio Techne currently has 158,891,800 shares in issue. The market capitalisation of Bio Techne is US$12.51 billion. Bio Techne has a price to earnings ratio (PE ratio) of 74.40.

TECH 최신 뉴스

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio PR Newswire ST. PAUL, Minn., Jan. 21, 2025 ST. PAUL, Minn., Jan. 21, 2025 /PRNewswire/ -- ScaleReady, in collaboration with...

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire MINNEAPOLIS, Jan. 10, 2025 MINNEAPOLIS, Jan. 10, 2025...

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire ST. PAUL, Minn., Jan. 8, 2025 ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in...

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire MINNEAPOLIS, Jan. 7, 2025 MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...

ScaleReady awards a G-Rex® Grant to Moonlight Bio

ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
12.573.3753611767876.1479.773.6791268176.47284228CS
46.38.7004557381672.4179.770.75574570774.81099388CS
124.716.364864864867480.865.6190396373.61906541CS
262.363.0910281597976.3583.6265.6189394674.19915377CS
527.7710.952917958870.9485.5761.1696932573.39281185CS
156-12.51-13.714097785691.22113.80551.7978298275.8145937CS
26023.137541.634801385655.5725135.962538.792555738278.05681528CS

TECH - Frequently Asked Questions (FAQ)

What is the current Bio Techne share price?
The current share price of Bio Techne is US$ 78.71
How many Bio Techne shares are in issue?
Bio Techne has 158,891,800 shares in issue
What is the market cap of Bio Techne?
The market capitalisation of Bio Techne is USD 12.51B
What is the 1 year trading range for Bio Techne share price?
Bio Techne has traded in the range of US$ 61.16 to US$ 85.57 during the past year
What is the PE ratio of Bio Techne?
The price to earnings ratio of Bio Techne is 74.4
What is the cash to sales ratio of Bio Techne?
The cash to sales ratio of Bio Techne is 10.79
What is the reporting currency for Bio Techne?
Bio Techne reports financial results in USD
What is the latest annual turnover for Bio Techne?
The latest annual turnover of Bio Techne is USD 1.16B
What is the latest annual profit for Bio Techne?
The latest annual profit of Bio Techne is USD 168.11M
What is the registered address of Bio Techne?
The registered address for Bio Techne is 614 MCKINLEY PLACE N.E, MINNEAPOLIS, MINNESOTA, 55413
What is the Bio Techne website address?
The website address for Bio Techne is www.bio-techne.com
Which industry sector does Bio Techne operate in?
Bio Techne operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BLBXBlackBoxStocks Inc
US$ 5.53
(227.22%)
229.08M
ASSTAsset Entities Inc
US$ 1.36
(51.11%)
121.68M
STAIScanTech AI Systems Inc
US$ 2.12
(44.22%)
51.68M
JYDJayud Global Logistics Ltd
US$ 3.53
(42.91%)
1.27M
NTRBNutriband Inc
US$ 7.39
(41.84%)
3.88M
STFSStar Fashion Culture Holdings Ltd
US$ 2.62
(-80.61%)
30.25M
HEPAHepion Pharmaceuticals Inc
US$ 0.135
(-58.05%)
39.89M
STBXStarBox Group Holdings Ltd
US$ 0.6201
(-36.50%)
1.63M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 93.51
(-35.73%)
1
JUNSJupiter Neurosciences Inc
US$ 3.61
(-33.39%)
6.87M
IPAImmunoPrecise Antibodies Ltd
US$ 0.6446
(30.75%)
296.43M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3191
(33.57%)
229.11M
BLBXBlackBoxStocks Inc
US$ 5.53
(227.22%)
229.08M
NVDANVIDIA Corporation
US$ 147.07
(4.43%)
216.62M
RGTIRigetti Computing Inc
US$ 13.89
(-0.64%)
154.54M

TECH Discussion

게시물 보기
Monksdream Monksdream 3 월 전
TECH under $75
👍️0
Monksdream Monksdream 4 월 전
TECH range bound
👍️0
Monksdream Monksdream 6 월 전
TECH under $100
👍️0
LordTurkeyBaster LordTurkeyBaster 3 년 전
Top Meme Stock Mentions Money to Move 01/03/2022

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 년 전
Top Meme Stock Mentions Money to Move 10/15/2021

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 년 전
Top Meme Stock Mentions Money to Move 10/14/2021

$TECH: $1B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
TREND1 TREND1 10 년 전
NO REASON.
👍️0
getarealjob getarealjob 10 년 전
No worries, just read a blurb on a new diet drug that sounds pretty promising from these guys. Fexaramine, from these guys, looking at clinicals in 2-3 years.

Is there a reason you're no longer following it or just got tired and needed more time with others?
👍️0
TREND1 TREND1 10 년 전
NO longer follow TECH.
SORRY
👍️0
getarealjob getarealjob 10 년 전
Hey Trend, saw you over on AAL. This guy just popped up on my radar, obviously nothing going on in the board. What are your thoughts on this, if you have any beyond your charts? Not sure if you're on this one or not.
👍️0
TREND1 TREND1 10 년 전
TECH D
👍️0

최근 히스토리

Delayed Upgrade Clock